Kindred Biosciences (NASDAQ:KIN)

CAPS Rating: 5 out of 5

KIN News and Commentary

Caps

How do you think KIN will perform against the market?

Add Stock to CAPS Watchlist

All Players

20 Outperform
0 Underperform
 

All-Star Players

6 Outperform
0 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top KIN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

gbeberman (< 20)
Submitted August 03, 2015

KIN has a talented management team, including Richard Chin who had led productive drug development at places like Genentech. They will be filing for drug releases in 2016. And they manage their expenses so well that they have something like 16… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

KIN VS S&P 500 (SPY)

KIN Summary

Recent Community Commentary

Read the most recent pitches from players about KIN.

Recs

0
Member Avatar oscillation (66.55) Submitted: 11/22/2015 10:00:50 PM : Outperform Start Price: $4.04 KIN Score: +88.09

nev

Recs

1
Member Avatar gbeberman (< 20) Submitted: 8/3/2015 1:07:09 PM : Outperform Start Price: $6.18 KIN Score: +17.05

KIN has a talented management team, including Richard Chin who had led productive drug development at places like Genentech. They will be filing for drug releases in 2016. And they manage their expenses so well that they have something like 16 quarters worth of liquid assets to take them forward.

These are both talented scientists and smart business people.

Recs

0
Member Avatar tiobueno (99.12) Submitted: 10/1/2014 5:18:03 AM : Outperform Start Price: $9.51 KIN Score: -36.85

NODELMAN OLEG Director Sep 29 Buy 9.56 100,000 955,970 614,495 Sep 30 05:03 PM

Leaderboard

Find the members with the highest scoring picks in KIN.

Score Leader

mswanhart77

mswanhart77 (60.59) Score: +113.72

The Score Leader is the player with the highest score across all their picks in KIN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mswanhart77 60.59 4/18/2016 Outperform 5Y $3.57 +131.09% +17.37% +113.72 0 Comment
oscillation 66.55 11/23/2015 Outperform 5Y $4.04 +104.21% +16.12% +88.09 1 Comment
manirg < 20 10/17/2016 Outperform 5Y $5.45 +51.38% +14.40% +36.97 0 Comment
PavsElliotWave 80.89 5/9/2017 Outperform 5Y $6.70 +23.13% +1.32% +21.81 0 Comment
gbeberman < 20 8/3/2015 Outperform 5Y $6.18 +33.54% +16.49% +17.05 1 Comment
getrichdietrying 82.66 6/19/2017 Outperform 5Y $7.10 +16.20% -0.19% +16.39 0 Comment
shonny2 < 20 2/6/2017 Outperform 5Y $6.85 +20.44% +6.23% +14.21 0 Comment
jck444 87.42 3/21/2017 Outperform 5Y $7.20 +14.58% +3.84% +10.74 0 Comment
smegmacles 42.97 2/12/2015 Outperform 3Y $6.65 +24.06% +16.85% +7.21 0 Comment
gunda7907 < 20 1/2/2015 Outperform 5Y $7.21 +14.42% +18.64% -4.22 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.49 4/7/2014 Outperform 3W $17.44 -52.69% +31.89% -84.59 0 Comment
TrackBMOCapital < 20 1/6/2014 Outperform NS $10.40 -20.67% +32.52% -53.19 0 Comment

Featured Broker Partners